Life sciences firm Zucara Therapeutics Inc. has secured non-dilutive funding of US$3.9 million for the pre-clinical advancement of its lead drug candidate for diabetes, ZT-01. Zucara’s partner, The Leona M. and Harry B. Helmsley Charitable Trust, will provide the funds in the form of a loan under a program-related investment (PRI). ZT-01 is focused on the prevention of hypoglycemia or dangerously low blood glucose levels, which may lead to unconsciousness or death, in patients with Type 1 diabetes (T1D) and other types of insulin-dependent diabetes. For its lead drug to be on schedule for Phase I clinical trials in 2019, Zucara is pushing forward with GLP toxicology, GMP manufacturing and other investigational new drug/clinical trial application enabling activities. Zucara chief scientific officer Richard Liggins, who has helped several similar-stage therapeutics reach clinical trials, will lead the preclinical development work. To build and advance its products, Zucara is working closely with the Centre for Drug Research and Development (CDRD).
Trending by Topic
Research Money News
R$ Welcomes New Team Member
We’re delighted to welcome Mark Lowey as senior correspondent for Research Money.Read More
Role Models Matter
The latest issue of Canadian Innovation News is now available for free.Read More
RE$EARCH MONEY welcomes its readers to submit articles of either 650 or 1,000 words for its popular Opinion Leader page, on topics of interest to the research and innovation community. We also welcome Letters to the Editor and other feedback. If you would like to submit an article or if your organization has news or events that it would like to appear in RE$EARCH MONEY please contact Mark Henderson, Managing Editor, for further information.
- National Research Council
- Natural Sciences and Engineering Research Council
- Canada Foundation for Innovation
- Univ of Toronto
- Univ of British Columbia
- Canadian Institutes of Health Research
- Technology Partnerships Canada
- McGill Univ
- Univ of Alberta
- Univ of Waterloo
Research Money on Twitter
- Loading tweets...